Interestingly, other ABC transporter genes that have been described to confer resistance in cell lines with acquired doxorubicin (e.g., ABCC1, ABCC2, and ABCG2) were not related to inherent anthracycline resistance in this panel of tumor cell lines. This evidence concerns the gene ABCG2 and neoplasm.